Common antidepressant could be new weapon against severe asthma flare-ups
NCT ID NCT06216535
Summary
This study is testing whether escitalopram, a common antidepressant, can help reduce the number of severe asthma attacks in adults who continue to have frequent flare-ups despite using standard high-dose inhalers. Researchers will compare the drug to a placebo (inactive pill) over 26 weeks in 105 participants. The goal is to see if this medication, which affects brain chemicals, can also help control asthma and improve quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UT Southwestern, 1440 Empire Central, Ste. LD4.100
RECRUITINGDallas, Texas, 75247, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.